Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2336-2340, June 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Undén, A. B.
Right arrow Articles by Ståhle-Bäckdahl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Undén, A. B.
Right arrow Articles by Ståhle-Bäckdahl, M.

Human patched (PTCH) mRNA Is Overexpressed Consistently in Tumor Cells of Both Familial and Sporadic Basal Cell Carcinoma1

Anne Birgitte Undén, Peter G. Zaphiropoulos, Kerstin Bruce, Rune Toftgård and Mona Ståhle-Bäckdahl2

Department of Dermatology, Karolinska Hospital, S-17176 Stockholm [A. B. U., K. B., M. S-B.]; and Department of Bioscience, Center for Nutrition and Toxicology, Karolinska Institute, Novum, S-14157 Huddinge [A. B. U., P. G. Z., R. T.], Sweden

Recently, a human homologue of the Drosophila patched gene, PTCH, was identified as a putative tumor suppressor mutated in both hereditary and sporadic basal cell carcinomas. Because PTCH controls its own transcription, inactivating mutations in PTCH may lead to overexpression of mutant PTCH mRNA due to loss of autoregulation. The present study is aimed at evaluating whether deregulation of PTCH mRNA expression is a general feature of BCCs of varying histological growth pattern and malignant potential.

Irrespective of histological subtype, PTCH mRNA was overexpressed consistently as determined by in situ hybridization in all of the sporadic (n = 16) and hereditary (n = 20) tumors examined. PTCH expression was found in all of the tumor cells but appeared stronger in the peripheral palisading cells. PTCH mRNA was not detected in adjacent nontumor epidermal cells or in other parts of the epidermis. In the majority of tumors (20 of 36), nuclear immunostaining for p53 was found in scattered cells, whereas seven tumors completely lacked p53 immunoreactivity.

Our finding of an up-regulation of PTCH mRNA levels in all of the BCCs analyzed indicates that deregulation of the PTCH signaling pathway constitutes an early rate-limiting event in BCC development.

1 This work was supported by the Swedish Cancer Fund, the Welander-Finsen Foundation, the Swedish Radiation Protection Institute, the Swedish Children Cancer Fund, and the Karolinska Institute.

2 To whom requests for reprints should be addressed.

Received 3/14/97. Accepted 4/29/97.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. Grachtchouk, J. Liu, A. Wang, L. Wei, C. K. Bichakjian, J. Garlick, A. F. Paulino, T. Giordano, and A. A. Dlugosz
Odontogenic Keratocysts Arise from Quiescent Epithelial Rests and Are Associated with Deregulated Hedgehog Signaling in Mice and Humans
Am. J. Pathol., September 1, 2006; 169(3): 806 - 814.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Ma, K. Chen, S. Huang, X. Zhang, P. A. Adegboyega, B.M. Evers, H. Zhang, and J. Xie
Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas
Carcinogenesis, October 1, 2005; 26(10): 1698 - 1705.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
T. Kawabata, K. Takahashi, M. Sugai, A. Murashima-Suginami, S. Ando, A. Shimizu, S. Kosugi, T. Sato, M. Nishida, K. Murakami, et al.
Polymorphisms in PTCH1 Affect the Risk of Ameloblastoma
J. Dent. Res., September 1, 2005; 84(9): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Brancaccio, A. Minichiello, M. Grachtchouk, D. Antonini, H. Sheng, R. Parlato, N. Dathan, A. A. Dlugosz, and C. Missero
Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis
Hum. Mol. Genet., November 1, 2004; 13(21): 2595 - 2606.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Brellier, C. Marionnet, O. Chevallier-Lagente, R. Toftgard, A. Mauviel, A. Sarasin, and T. Magnaldo
Ultraviolet Irradiation Represses PATCHED Gene Transcription in Human Epidermal Keratinocytes through an Activator Protein-1-Dependent Process
Cancer Res., April 15, 2004; 64(8): 2699 - 2704.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Stegman, J. A. Goetz, M. Ascano Jr., S. K. Ogden, K. E. Nybakken, and D. J. Robbins
The Kinesin-related Protein Costal2 Associates with Membranes in a Hedgehog-sensitive, Smoothened-independent Manner
J. Biol. Chem., February 20, 2004; 279(8): 7064 - 7071.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Canamasas, A. Debes, P. G. Natali, and U. Kurzik-Dumke
Understanding Human Cancer Using Drosophila: Tid47, A CYTOSOLIC PRODUCT OF THE DnaJ-LIKE TUMOR SUPPRESSOR GENE l(2)Tid, IS A NOVEL MOLECULAR PARTNER OF PATCHED RELATED TO SKIN CANCER
J. Biol. Chem., August 15, 2003; 278(33): 30952 - 30960.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Hu, J. M. Bonifas, G. Aragon, L. Kopelovich, Y. Liang, S. Ohta, M. A. Israel, D. R. Bickers, M. Aszterbaum, and E. H. Epstein Jr.
Evidence for Lack of Enhanced Hedgehog Target Gene Expression in Common Extracutaneous Tumors
Cancer Res., March 1, 2003; 63(5): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
D.C. Barreto, A.E. Bale, L. De Marco, and R.S. Gomez
Immunolocalization of PTCH Protein in Odontogenic Cysts and Tumors
J. Dent. Res., November 1, 2002; 81(11): 757 - 760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Sheng, S. Goich, A. Wang, M. Grachtchouk, L. Lowe, R. Mo, K. Lin, F. J. de Sauvage, H. Sasaki, C.-c. Hui, et al.
Dissecting the Oncogenic Potential of Gli2: Deletion of an NH2-Terminal Fragment Alters Skin Tumor Phenotype
Cancer Res., September 15, 2002; 62(18): 5308 - 5316.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Niemann, D. M. Owens, J. Hulsken, W. Birchmeier, and F. M. Watt
Expression of {Delta}NLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours
Development, January 1, 2002; 129(1): 95 - 109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. G. Zaphiropoulos, A. B. Unden, F. Rahnama, R. E. Hollingsworth, and R. Toftgard
PTCH2, a Novel Human Patched Gene, Undergoing Alternative Splicing andUp-regulated in Basal Cell Carcinomas
Cancer Res., February 1, 1999; 59(4): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Nilsson, A. B. Unden, D. Krause, U. Malmqwist, K. Raza, P. G. Zaphiropoulos, and R. Toftgard
Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1
PNAS, March 28, 2000; 97(7): 3438 - 3443.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.